logo

For the Inventor, By the Inventor

Berkshire, United Kingdom

Celltech Therapeutics Limited


USPTO Granted Patents = 81

% Expired Patents = 2.5


Forward Citations = 3,646

Loading Chart...
Loading Chart...

57 inventors (with patents filed for the assignee):

goldMedal Graham John Warrellow (34 out of 59 patents)

silverMedal Rikki Peter Alexander (19 out of 41 patents)

bronzeMedal John Clifford Head (16 out of 38 patents)

4.  John Robert Porter (11 out of 67 patents)

5.  Sarah Catherine Archibald (10 out of 26 patents)

6.  Peter David Davis (9 out of 20 patents)

7.  Thomas A Millican (8 out of 19 patents)

8.  Ewan C Boyd (8 out of 9 patents)

9.  David Festus Moffat (7 out of 7 patents)

10.  Nigel Robert Beeley (7 out of 11 patents)

11.  Diljeet Singh Athwal (6 out of 21 patents)

12.  Mark William Bodmer (6 out of 12 patents)

13.  Martin Clive Hutchings (5 out of 22 patents)

14.  Jeremy Martin Davis (5 out of 19 patents)

15.  John Robert Adair (5 out of 18 patents)


Core Competencies:
Recombinant Antibodies
Protein Kinase Inhibitors
Metalloproteinase Derivatives
Humanized Antibodies
Cinnamic Acid Derivatives
Phenylalanine Derivatives
Nucleic Acids
CD3 Specific Antibody
Trisubstituted Phenyl Derivatives
Peptidyl Derivatives
Tyrosine Kinase Inhibitors
Fusion Proteins

81 patents:

1. 7105160 - Antibody-serum protein hybrids (2006-09-12),
2. 7052876 - Combinatorial method for producing nucleic acids (2006-05-30),
3. 6642356 - Peptides which function as hinge regions in protein (2003-11-04),
4. 6632927 - Humanized antibodies (2003-10-14),
5. 6465471 - Cinnamic acid derivatives (2002-10-15),
6. 6407214 - Antibodies against E-selectin (2002-06-18),
7. 6369229 - Pyridylalanine derivatives (2002-04-09),
8. 6362204 - Phenylalanine derivatives (2002-03-26),
9. 6348463 - Phenylalanine derivatives (2002-02-19),
10. 6337335 - Substituted 2-anilinopyrimidines useful as protein kinase inhibitors (2002-01-08),
11. 6329372 - Phenylalanine derivatives (2001-12-11),
12. 6329362 - Cinnamic acid derivatives (2001-12-11),
13. 6319922 - Propanoic acid derivatives (2001-11-20),
14. 6316227 - Nucleic acids encoding interleukin-5 specific recombinant antibodies (2001-11-13),
15. 6297264 - Trisubstituted phenyl derivatives and process for their preparation (2001-10-02),
Celltech Therapeutics Limited is a leading biopharmaceutical company specializing in the research, development, and commercialization of innovative therapies for various diseases. With a strong focus on cell-based therapies, we aim to revolutionize healthcare by offering personalized treatments. Our dedicated team of scientists, researchers, and healthcare professionals is committed to improving patient outcomes and transforming the future of medicine.
This text is generated by artificial intelligence and may not be accurate.

logo

Company Badge

USPTO Data Jan 1 1976 - Sep 22 2026

81 Patents

#1 in Berkshire

#228 in United Kingdom

#9,334 in the World

Berkshire, GB
Berkshire, United Kingdom

Celltech Therapeutics Limited

Forward Citations = 3,646

57 inventors:

goldMedal Graham John Warrellow (34 out of 59 patents)

silverMedal Rikki Peter Alexander (19 out of 41 patents)

bronzeMedal John Clifford Head (16 out of 38 patents)

4.  John Robert Porter (11 out of 67 patents)

5.  Sarah Catherine Archibald (10 out of 26 patents)

Please report any incorrect information to [email protected]
Loading…